April 24, 2014 1:18 PM ET

Pharmaceuticals

Company Overview of PLx Pharma Inc.

Company Overview

PLx Pharma Inc., a specialty pharmaceutical company, develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets in the United States. It develops gastrointestinal (GI) safer formulations of proven non-steroidal anti-inflammatory drugs, including aspirin, ibuprofen, and indomethacin, as well as other drugs for over-the-counter and prescription markets. It offers products in the areas of gout, cancer prevention, and pediatric; GI-safer aspirin for cardio prevention; GI safer Rx and OTC products for the treatment of arthritis, pain, and fever; and GI safer Rx products for post-operative pain and patent ductus arteriosus. The company is based ...

8285 El Rio

Suite 130

Houston, TX 77054

United States

Phone:

713-842-1249

Fax:

713-842-3052

Key Executives for PLx Pharma Inc.

Chief Executive Officer
Chairman and Member of Chief Executive officer of Advisory Group
Age: 58
Scientific Founder
Chief Operating Officer and Director
Age: 72
Senior Vice President
Compensation as of Fiscal Year 2013.

PLx Pharma Inc. Key Developments

Food and Drug Administration Accepts Review of PLx Pharma Inc.'s New Drug Application for PL2200 Aspirin 325 mg; Appoints Peter Mann to its Board of Directors

PLx Pharma Inc. reported that the united states food and drug administration has accepted for review a new drug application for PL2200 Aspirin 325 mg. The company is developing PL2200 Aspirin 325 mg for sale Over-the-Counter. With the PL2200 NDA filing, a significant milestone has been reached bringing this novel first-to-market, liquid-filled aspirin product closer to commercialization. The company has elected Peter Mann to its Board of Directors. Peter Mann is a founding partner with Yellow Wood Partners, an investment firm focused on branded consumer packaged goods. Prior to Yellow Wood Partners, Peter co-founded Blacksmith Brands Inc. in 2009 and as Chairman and CEO led the acquisition of a group of brands from a major pharmaceutical company, rejuvenated them and then successfully sold the company in 2010.

Similar Private Companies By Industry

Company Name Region
OncoFusion Therapeutics Inc. United States
Bellicum Pharmaceuticals, Inc. United States
SiCap Industries, LLC United States
PetLife Organic, Inc. United States
The Chemins Company, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 28, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PLx Pharma Inc., please visit www.plxpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.